StockData
Neuronetics, Inc. logo

Neuronetics, Inc. (STIM) stock

STIMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$1.28+0.03 (+2.40%)

Close on Nov 17, 2026Market cap $97.53MP/E –Yield –

Neuronetics total assets

Total assets on the balance sheet at the end of each period.

Neuronetics's total assets was $131.53M at Jun 30, 2026. For fiscal 2025 it was $141.55M, up 0.5% from the year before. The highest annual figure on record is $141.55M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$141.55M+0.5%
FY2024Dec 31, 2024$140.90M+21.6%
FY2023Dec 31, 2023$115.83M-0.9%
FY2022Dec 31, 2022$116.88M-17.2%
FY2021Dec 31, 2021$141.22M+79.5%
FY2020Dec 31, 2020$78.66M-21.5%
FY2019Dec 31, 2019$100.17M-14.4%
FY2018Dec 31, 2018$117.02M+200.5%
FY2017Dec 31, 2017$38.94M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$131.53M-2.3%
Q1 FY2026Mar 31, 2026$125.44M-11.7%
Q4 FY2025Dec 31, 2025$141.55M+0.5%
Q3 FY2025Sep 30, 2025$145.47M+96.3%
Q2 FY2025Jun 30, 2025$134.65M+39.1%
Q1 FY2025Mar 31, 2025$141.99M+36.8%
Q4 FY2024Dec 31, 2024$140.90M+21.6%
Q3 FY2024Sep 30, 2024$74.12M-20.3%
Q2 FY2024Jun 30, 2024$96.81M-3.6%
Q1 FY2024Mar 31, 2024$103.81M+0.2%
Q4 FY2023Dec 31, 2023$115.83M-0.9%
Q3 FY2023Sep 30, 2023$92.99M-22.0%
Q2 FY2023Jun 30, 2023$100.39M-18.3%
Q1 FY2023Mar 31, 2023$103.60M-20.3%
Q4 FY2022Dec 31, 2022$116.88M-17.2%
Q3 FY2022Sep 30, 2022$119.24M-16.7%
Q2 FY2022Jun 30, 2022$122.95M-17.0%
Q1 FY2022Mar 31, 2022$129.94M-14.7%
Q4 FY2021Dec 31, 2021$141.22M+79.5%
Q3 FY2021Sep 30, 2021$143.07M+82.6%
Q2 FY2021Jun 30, 2021$148.10M+85.1%
Q1 FY2021Mar 31, 2021$152.31M+72.2%
Q4 FY2020Dec 31, 2020$78.66M-21.5%
Q3 FY2020Sep 30, 2020$78.34M-25.7%
Q2 FY2020Jun 30, 2020$79.99M-26.9%
Q1 FY2020Mar 31, 2020$88.46M-22.0%
Q4 FY2019Dec 31, 2019$100.17M-14.4%
Q3 FY2019Sep 30, 2019$105.48M-11.3%
Q2 FY2019Jun 30, 2019$109.43M+286.1%
Q1 FY2019Mar 31, 2019$113.44M+191.3%
Q4 FY2018Dec 31, 2018$117.02M–
Q3 FY2018Sep 30, 2018$118.98M–
Q2 FY2018Jun 30, 2018$28.35M–
Q4 FY2017Dec 31, 2017$38.94M–

More Neuronetics figures

See a number that looks wrong?